Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1

Interventions

X-Rays 5 Phantoms, Imaging 5 Magnetic Resonance Spectroscopy 5 Nuclear Medicine Department, Hospital 4 Cyclophosphamide 4 fludarabine 3 Specimen Handling 3 Doxorubicin 3 Biopsy 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 olaparib 2 larotrectinib 2 ivosidenib 2 ensartinib 2 cabozantinib 2 Methotrexate 2 Mesna 2 Ifosfamide 2 Gemcitabine 2 Eflornithine 2 Cisplatin 2 tazemetostat 1 talazoparib 1 selinexor 1 pazopanib 1 palbociclib 1 mifamurtide 1 merphos 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Pafolacianine × 30 days × Clear all

NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡